The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pigmentation Disorder Therapeutic Market Research Report 2025

Global Pigmentation Disorder Therapeutic Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1713842

No of Pages : 89

Ask Your Query

Synopsis
Market Analysis and Insights: Global Pigmentation Disorder Therapeutic Market

Skin pigmentation refers to a skin disorder that causes either lightening of skin or darkening of skin when compared to the existing skin color.

The global Pigmentation Disorder Therapeutic market size is projected to reach US$ 8575.7 million by 2028, from US$ 6061.9 million in 2021, at a CAGR of 5.0% during 2022-2028.

Pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, photOthersapy, and laser therapy. These therapies are available in hospitals and aesthetic clinics & dermatology centers.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pigmentation Disorder Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pigmentation Disorder Therapeutic market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pigmentation Disorder Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pigmentation Disorder Therapeutic market.

Global Pigmentation Disorder Therapeutic Scope and Market Size
Pigmentation Disorder Therapeutic market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pigmentation Disorder Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.)
  • Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)

Segment by Application

  • Dermatology Clinics
  • Drugstores and Cosmetic Stores
  • Aesthetic Clinics
  • E-commerce
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Bayer
  • Allergan
  • Episciences
  • La Roche-Posay
  • Skinceuticals
  • Pierre Fabre
  • Alvogen
  • Obagi
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pigmentation Disorder Therapeutic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.)
1.2.3 Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)
1.3 Market by Application
1.3.1 Global Pigmentation Disorder Therapeutic Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Dermatology Clinics
1.3.3 Drugstores and Cosmetic Stores
1.3.4 Aesthetic Clinics
1.3.5 E-commerce
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pigmentation Disorder Therapeutic Market Perspective (2017-2028)
2.2 Pigmentation Disorder Therapeutic Growth Trends by Region
2.2.1 Pigmentation Disorder Therapeutic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pigmentation Disorder Therapeutic Historic Market Size by Region (2017-2022)
2.2.3 Pigmentation Disorder Therapeutic Forecasted Market Size by Region (2023-2028)
2.3 Pigmentation Disorder Therapeutic Market Dynamics
2.3.1 Pigmentation Disorder Therapeutic Industry Trends
2.3.2 Pigmentation Disorder Therapeutic Market Drivers
2.3.3 Pigmentation Disorder Therapeutic Market Challenges
2.3.4 Pigmentation Disorder Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pigmentation Disorder Therapeutic Players by Revenue
3.1.1 Global Top Pigmentation Disorder Therapeutic Players by Revenue (2017-2022)
3.1.2 Global Pigmentation Disorder Therapeutic Revenue Market Share by Players (2017-2022)
3.2 Global Pigmentation Disorder Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pigmentation Disorder Therapeutic Revenue
3.4 Global Pigmentation Disorder Therapeutic Market Concentration Ratio
3.4.1 Global Pigmentation Disorder Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pigmentation Disorder Therapeutic Revenue in 2021
3.5 Pigmentation Disorder Therapeutic Key Players Head office and Area Served
3.6 Key Players Pigmentation Disorder Therapeutic Product Solution and Service
3.7 Date of Enter into Pigmentation Disorder Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pigmentation Disorder Therapeutic Breakdown Data by Type
4.1 Global Pigmentation Disorder Therapeutic Historic Market Size by Type (2017-2022)
4.2 Global Pigmentation Disorder Therapeutic Forecasted Market Size by Type (2023-2028)
5 Pigmentation Disorder Therapeutic Breakdown Data by Application
5.1 Global Pigmentation Disorder Therapeutic Historic Market Size by Application (2017-2022)
5.2 Global Pigmentation Disorder Therapeutic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pigmentation Disorder Therapeutic Market Size (2017-2028)
6.2 North America Pigmentation Disorder Therapeutic Market Size by Country (2017-2022)
6.3 North America Pigmentation Disorder Therapeutic Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Pigmentation Disorder Therapeutic Market Size (2017-2028)
7.2 Europe Pigmentation Disorder Therapeutic Market Size by Country (2017-2022)
7.3 Europe Pigmentation Disorder Therapeutic Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pigmentation Disorder Therapeutic Market Size (2017-2028)
8.2 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Country (2017-2022)
8.3 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Pigmentation Disorder Therapeutic Market Size (2017-2028)
9.2 Latin America Pigmentation Disorder Therapeutic Market Size by Country (2017-2022)
9.3 Latin America Pigmentation Disorder Therapeutic Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pigmentation Disorder Therapeutic Market Size (2017-2028)
10.2 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Country (2017-2022)
10.3 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Pigmentation Disorder Therapeutic Introduction
11.1.4 Bayer Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
11.1.5 Bayer Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Pigmentation Disorder Therapeutic Introduction
11.2.4 Allergan Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
11.2.5 Allergan Recent Development
11.3 Episciences
11.3.1 Episciences Company Detail
11.3.2 Episciences Business Overview
11.3.3 Episciences Pigmentation Disorder Therapeutic Introduction
11.3.4 Episciences Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
11.3.5 Episciences Recent Development
11.4 La Roche-Posay
11.4.1 La Roche-Posay Company Detail
11.4.2 La Roche-Posay Business Overview
11.4.3 La Roche-Posay Pigmentation Disorder Therapeutic Introduction
11.4.4 La Roche-Posay Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
11.4.5 La Roche-Posay Recent Development
11.5 SkinCeuticals
11.5.1 SkinCeuticals Company Detail
11.5.2 SkinCeuticals Business Overview
11.5.3 SkinCeuticals Pigmentation Disorder Therapeutic Introduction
11.5.4 SkinCeuticals Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
11.5.5 SkinCeuticals Recent Development
11.6 Pierre Fabre
11.6.1 Pierre Fabre Company Detail
11.6.2 Pierre Fabre Business Overview
11.6.3 Pierre Fabre Pigmentation Disorder Therapeutic Introduction
11.6.4 Pierre Fabre Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
11.6.5 Pierre Fabre Recent Development
11.7 Alvogen
11.7.1 Alvogen Company Detail
11.7.2 Alvogen Business Overview
11.7.3 Alvogen Pigmentation Disorder Therapeutic Introduction
11.7.4 Alvogen Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
11.7.5 Alvogen Recent Development
11.8 Obagi
11.8.1 Obagi Company Detail
11.8.2 Obagi Business Overview
11.8.3 Obagi Pigmentation Disorder Therapeutic Introduction
11.8.4 Obagi Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
11.8.5 Obagi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Pigmentation Disorder Therapeutic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.)
Table 3. Key Players of Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)
Table 4. Global Pigmentation Disorder Therapeutic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Pigmentation Disorder Therapeutic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Pigmentation Disorder Therapeutic Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Pigmentation Disorder Therapeutic Market Share by Region (2017-2022)
Table 8. Global Pigmentation Disorder Therapeutic Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Pigmentation Disorder Therapeutic Market Share by Region (2023-2028)
Table 10. Pigmentation Disorder Therapeutic Market Trends
Table 11. Pigmentation Disorder Therapeutic Market Drivers
Table 12. Pigmentation Disorder Therapeutic Market Challenges
Table 13. Pigmentation Disorder Therapeutic Market Restraints
Table 14. Global Pigmentation Disorder Therapeutic Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Pigmentation Disorder Therapeutic Market Share by Players (2017-2022)
Table 16. Global Top Pigmentation Disorder Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pigmentation Disorder Therapeutic as of 2021)
Table 17. Ranking of Global Top Pigmentation Disorder Therapeutic Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Pigmentation Disorder Therapeutic Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pigmentation Disorder Therapeutic Product Solution and Service
Table 21. Date of Enter into Pigmentation Disorder Therapeutic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pigmentation Disorder Therapeutic Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Pigmentation Disorder Therapeutic Revenue Market Share by Type (2017-2022)
Table 25. Global Pigmentation Disorder Therapeutic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Pigmentation Disorder Therapeutic Revenue Market Share by Type (2023-2028)
Table 27. Global Pigmentation Disorder Therapeutic Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Pigmentation Disorder Therapeutic Revenue Market Share by Application (2017-2022)
Table 29. Global Pigmentation Disorder Therapeutic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Pigmentation Disorder Therapeutic Revenue Market Share by Application (2023-2028)
Table 31. North America Pigmentation Disorder Therapeutic Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Pigmentation Disorder Therapeutic Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Pigmentation Disorder Therapeutic Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Pigmentation Disorder Therapeutic Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Pigmentation Disorder Therapeutic Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Pigmentation Disorder Therapeutic Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Country (2023-2028) & (US$ Million)
Table 41. Bayer Company Detail
Table 42. Bayer Business Overview
Table 43. Bayer Pigmentation Disorder Therapeutic Product
Table 44. Bayer Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
Table 45. Bayer Recent Development
Table 46. Allergan Company Detail
Table 47. Allergan Business Overview
Table 48. Allergan Pigmentation Disorder Therapeutic Product
Table 49. Allergan Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
Table 50. Allergan Recent Development
Table 51. Episciences Company Detail
Table 52. Episciences Business Overview
Table 53. Episciences Pigmentation Disorder Therapeutic Product
Table 54. Episciences Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
Table 55. Episciences Recent Development
Table 56. La Roche-Posay Company Detail
Table 57. La Roche-Posay Business Overview
Table 58. La Roche-Posay Pigmentation Disorder Therapeutic Product
Table 59. La Roche-Posay Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
Table 60. La Roche-Posay Recent Development
Table 61. SkinCeuticals Company Detail
Table 62. SkinCeuticals Business Overview
Table 63. SkinCeuticals Pigmentation Disorder Therapeutic Product
Table 64. SkinCeuticals Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
Table 65. SkinCeuticals Recent Development
Table 66. Pierre Fabre Company Detail
Table 67. Pierre Fabre Business Overview
Table 68. Pierre Fabre Pigmentation Disorder Therapeutic Product
Table 69. Pierre Fabre Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
Table 70. Pierre Fabre Recent Development
Table 71. Alvogen Company Detail
Table 72. Alvogen Business Overview
Table 73. Alvogen Pigmentation Disorder Therapeutic Product
Table 74. Alvogen Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
Table 75. Alvogen Recent Development
Table 76. Obagi Company Detail
Table 77. Obagi Business Overview
Table 78. Obagi Pigmentation Disorder Therapeutic Product
Table 79. Obagi Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
Table 80. Obagi Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pigmentation Disorder Therapeutic Market Share by Type: 2021 VS 2028
Figure 2. Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.) Features
Figure 3. Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.) Features
Figure 4. Global Pigmentation Disorder Therapeutic Market Share by Application in 2021 & 2028
Figure 5. Dermatology Clinics Case Studies
Figure 6. Drugstores and Cosmetic Stores Case Studies
Figure 7. Aesthetic Clinics Case Studies
Figure 8. E-commerce Case Studies
Figure 9. Others Case Studies
Figure 10. Pigmentation Disorder Therapeutic Report Years Considered
Figure 11. Global Pigmentation Disorder Therapeutic Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Pigmentation Disorder Therapeutic Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Pigmentation Disorder Therapeutic Market Share by Region: 2021 VS 2028
Figure 14. Global Pigmentation Disorder Therapeutic Market Share by Players in 2021
Figure 15. Global Top Pigmentation Disorder Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pigmentation Disorder Therapeutic as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Pigmentation Disorder Therapeutic Revenue in 2021
Figure 17. North America Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Pigmentation Disorder Therapeutic Market Share by Country (2017-2028)
Figure 19. United States Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Pigmentation Disorder Therapeutic Market Share by Country (2017-2028)
Figure 23. Germany Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Pigmentation Disorder Therapeutic Market Share by Region (2017-2028)
Figure 31. China Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Pigmentation Disorder Therapeutic Market Share by Country (2017-2028)
Figure 39. Mexico Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Pigmentation Disorder Therapeutic Market Share by Country (2017-2028)
Figure 43. Turkey Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Bayer Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
Figure 46. Allergan Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
Figure 47. Episciences Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
Figure 48. La Roche-Posay Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
Figure 49. SkinCeuticals Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
Figure 50. Pierre Fabre Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
Figure 51. Alvogen Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
Figure 52. Obagi Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock